Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	3.50B
Revenue (ttm)	1.51B
Net Income (ttm)	505.28M
Shares Out	22.75M
EPS (ttm)	22.21
PE Ratio	6.93
Forward PE	n/a
Dividend	4.00 (2.60%)
Ex-Dividend Date	Nov 13, 2024

Volume	535,733
Average Volume	331,955
Open	152.08
Previous Close	152.08
Day's Range	150.00 - 154.00
52-Week Range	35.50 - 168.00
Beta	0.23
RSI	66.01
Earnings Date	Sep 14, 2025

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.